Arturo Araya - Net Worth and Insider Trading
Arturo Araya Net Worth
The estimated net worth of Arturo Araya is at least $2,113 dollars as of 2024-09-20. Arturo Araya is the Chief Commercial Officer of Brainstorm Cell Therapeutics Inc and owns about 8,608 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $2,113. Details can be seen in Arturo Araya's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arturo Araya has not made any transactions after 2019-12-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arturo Araya
Arturo Araya Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arturo Araya owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Arturo Araya’s form 4 insider trades.
Insider Ownership Summary of Arturo Araya
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-24 | Chief Commercial Officer |
Arturo Araya Latest Holdings Summary
Arturo Araya currently owns a total of 1 stock. Arturo Araya owns 8,608 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of December 24, 2019, with a value of $2,113.
Latest Holdings of Arturo Araya
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-24 | 8,608 | 0.25 | 2,113 |
Holding Weightings of Arturo Araya
Arturo Araya Form 4 Trading Tracker
According to the SEC Form 4 filings, Arturo Araya has made a total of 1 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 3,000 shares on December 24, 2019, which cost Arturo Araya around $11,700.
Insider Trading History of Arturo Araya
- 1
Arturo Araya Trading Performance
GuruFocus tracks the stock performance after each of Arturo Araya's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arturo Araya is 17.47%. GuruFocus also compares Arturo Araya's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arturo Araya within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arturo Araya's insider trading performs compared to the benchmark.
Performance of Arturo Araya
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.81 | | | | | |
| Relative Return to S&P 500(%) | 2.57 | | | | | |
Arturo Araya Ownership Network
Arturo Araya Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Arturo Araya is the Chief Commercial Officer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Arturo Araya made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 566,372 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 0 shares, with a net sale of 63,000 shares. During the past 18 months, 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 577,872 shares were bought by its insiders, resulting in a net purchase of 514,872 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Arturo Araya Mailing Address
Above is the net worth, insider trading, and ownership report for Arturo Araya. You might contact Arturo Araya via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 3 University Plaza Drive, Suite 320, Hackensack Nj 07601.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
